DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Fasching PA, Bardia A, Nusch A. et al.
Pooled analysis of patient (pt)-reported quality of life (QOL) in the MONALEESA (ML)-2, -3, and -7 trials of ribociclib (RIB) plus endocrine therapy (ET) to treat hormone receptor–positive, HER2-negative (HR+/HER2−) advanced breast cancer (ABC).
Ann Oncol 2020;
31 (Suppl. 04) S348-S395
doi:10.1016/annonc/annonc268
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.